Navigation Links
JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS
Date:8/6/2013

Total revenues for the quarter ended June 30, 2013 included net sales, royalties and contract revenues.  Tables showing net sales for the three and six months ended June 30, 2013 compared to actual and pro forma net sales for the same periods in 2012 are included in this press release.

Net sales for the second quarter of 2013 were as follows:

  • Xyrem® (sodium oxybate) oral solution:  Xyrem net sales increased by 50% to $133.7 million in the second quarter of 2013 compared to $89.1 million in the second quarter of 2012.  During the second quarter of 2013, the average number of active Xyrem patients was approximately 10,700.
  • Erwinaze®/Erwinase® (asparaginase Erwinia chrysanthemi):  Erwinaze/ Erwinase worldwide net sales increased to $44.9 million in the second quarter of 2013 compared to pro forma net sales of $32.9 million in the second quarter of 2012, or an increase of 36% on a pro forma basis.  Erwinaze/Erwinase pro forma net sales represent net product sales as if the acquisition of EUSA Pharma had been completed on January 1, 2012.
  • Prialt® (ziconotide) intrathecal infusion:  Net sales of Prialt were $4.7 million in the second quarter of 2013 compared to net sales of $5.6 million for the same period of 2012.  During the second quarter of 2013, net sales were impacted by the transition to an exclusive specialty pharmacy, which is accessed through our Navigator Reimbursement and Access Program™ for Prialt.
  • Psychiatry Products:  Net sales of the company's psychiatry products were $11.8 million in the second quarter of 2013 compared to net sales of $19.8 million for the same period of 2012.  Second quarter 2013 net sales of the psychiatry products were impacted by continued generic competition.
  • Other:  Net sales of other products for the second quarter of 2013 were $11.5 million compare
    '/>"/>

  • SOURCE Jazz Pharmaceuticals plc
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Cumberland Pharmaceuticals Reports Second Quarter Financial Results
    2. Inovio Pharmaceuticals Responds to Market Activity
    3. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
    4. Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb
    5. Avanir Pharmaceuticals to Participate in Two Conferences in August
    6. Imprimis Pharmaceuticals, Inc. to Present at the Southern California Investor Conference on Thursday, August 8, 2013 at the Island Hotel in Newport Beach, CA. The presentation is scheduled to begin at 11 a.m. ET / 8 a.m. PT
    7. AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
    8. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
    9. Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference
    10. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
    11. GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... N.C. , April 17, 2015 ... the Integrated Embolic Protection™ filter platform for angioplasty ... of a $5.6 million Series B financing round ... venture firm with a focus on medical devices, ... The round also included Mountain Group Partners, Lookout ...
    (Date:4/17/2015)... CHICAGO, Ill. , April 17, 2015  AbbVie Inc. ... today announced that it has extended the expiration of its ... common stock of Pharmacyclics, Inc. to 5 p.m., ... On April 17, 2015, AbbVie also voluntarily ... Antitrust Improvements Act in order to provide the FTC with ...
    (Date:4/17/2015)... April 17, 2015 Inivata, a ... today that their presence at the 2015 American Association for ... by co-founder Nitzan Rosenfeld and a poster presentation. ... 18 th - 22 nd . The ... ctDNA , forms part of a session on ...
    Breaking Medicine Technology:Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2
    ... survival advantage ... standard therapy, -- First study to show survival advantage ... Pharmion Corporation,(Nasdaq: PHRM ) today announced that the ... approval of Thalidomide,Pharmion(R) for use in combination with melphalan and ...
    ... Appoints U.S. Biotest to Oversee Trials, PRINCETON, ... Board: DSCI), a provider of advanced wound care ... services agreement with San,Luis Obispo-based, privately held U.S. ... of DSC127, a novel and rapid wound-healing and,scar-reduction ...
    Cached Medicine Technology:Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 2Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 3Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 4Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 5Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 6Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells 2Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells 3Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells 4
    (Date:4/17/2015)... April 17, 2015 As a board-certified ... his new offering of platelet-rich plasma (PRP) ... (MOSM) is known for its world-class care of ... extensive surgical experience lacking in many other physicians offering ... treatments are utilized for pain management and rehabilitation. Dr. ...
    (Date:4/17/2015)... 2015 Baptist Health and The University ... partnership agreement designed to transform oncology care in northeast ... agreed to create a joint cancer program to enhance ... research. Baptist MD Anderson Cancer Center is anticipated to ... destination for highly coordinated, multidisciplinary cancer care for adults ...
    (Date:4/17/2015)... (PRWEB) April 17, 2015 Connie Casad, ... and functional medicine advocate with 30 years of practice ... be adding another level of service for her patients ... website of 10 recommended wellness books with a brief ... asked to explain her interest in providing this service, ...
    (Date:4/17/2015)... 17, 2015 Oxytocin is ... pituitary and thought to help mothers bond to their ... further substantiate this, new studies performed, at NYU Langone ... and reported by Medical News Today on April 16, ... over maternal social behavior. The study reveals that, when ...
    (Date:4/17/2015)... NY (PRWEB) April 17, 2015 Ticket Down is ... for their 2015 Summer Tour. , The life of last-minute show ... see the popular group perform during the early part of 2015, ... “I Will Wait,” “Little Lion Man,” “The Cave,” and “Believe,” will ... off on June 2 at MCU Park at Coney Island in ...
    Breaking Medicine News(10 mins):Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3Health News:Mumford and Sons Tickets in Clarkston/Detroit, Raleigh, Columbia/Baltimore, Chicago, Mansfield/Boston, Brooklyn, Calgary and Edmonton Now On Sale 2
    ... to a report published in the December issue of the ... residents improved their knowledge of health care business concepts and ... expectation is for residents to "demonstrate an awareness of and ... as well as the ability to call effectively on other ...
    ... of synthetic molecules to fish for disease-specific antibodies, researchers have ... simple blood test. The same methodology might lead to blood ... the January 7th issue of the journal Cell , ... disease, it suggests it is a pretty general platform that ...
    ... study to date of "Sarcoid Like" Granulomatous Pulmonary Disease in ... of the condition was increased in this group as compared ... published online in the American Journal of Industrial Medicine ... responders who had an initial exam in the Mount Sinai ...
    ... the first robotic assisted surgery for prostate cancer in ... Vattikuti Institute. Today, the majority prostate of cancer ... than 6,000 procedures have been performed during the past ... field will meet at the world,s largest medical robotic ...
    ... most widely produced fruit in the world and now ... nutrient which could tackle the onset of vascular diseases. ... & Food Research , reveals that an extracted compound, ... led by Dr Teruo Kawada, from Kyoto University and ...
    ... brain against developing Alzheimer,s and other forms of dementia, according ... study, published in the academic journal Phytomedicine , also ... in protecting the body against cancer., Led by Dr Ed ... properties of green tea which have previously been shown ...
    Cached Medicine News:Health News:Web-based curriculum improves surgical residents' knowledge of health care business 2Health News:A blood test for Alzheimer's disease? 2Health News:A blood test for Alzheimer's disease? 3Health News:Study of 'sarcoid-like' granulomatous pulmonary disease finds elevated rates in WTC responders 2Health News:Study of 'sarcoid-like' granulomatous pulmonary disease finds elevated rates in WTC responders 3Health News:10 years later: Robotic surgery for prostate cancer 2Health News:Protective properties of green tea uncovered 2
    Biopro rimmed acetabular is manufactured from titanium and is porous coated on the outside of its shell. The rimmed acetabular accommodates a polyethylene inert....
    The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
    The cementless acetabular shells form part of the Mallory head range of femoral and acetabular implants....
    Trident Hemispherical Acetabular Shells are a true hemispherical shape designed to achieve press-fit fixation by under-reaming the acetabulum....
    Medicine Products: